190 related articles for article (PubMed ID: 27267444)
1. MYC interaction with the tumor suppressive SWI/SNF complex member INI1 regulates transcription and cellular transformation.
Stojanova A; Tu WB; Ponzielli R; Kotlyar M; Chan PK; Boutros PC; Khosravi F; Jurisica I; Raught B; Penn LZ
Cell Cycle; 2016 Jul; 15(13):1693-705. PubMed ID: 27267444
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of MYC by the SMARCB1 tumor suppressor.
Weissmiller AM; Wang J; Lorey SL; Howard GC; Martinez E; Liu Q; Tansey WP
Nat Commun; 2019 May; 10(1):2014. PubMed ID: 31043611
[TBL] [Abstract][Full Text] [Related]
3. Chromatin-remodeling factor INI1/hSNF5/BAF47 is involved in activation of the colony stimulating factor 1 promoter.
Pan X; Song Z; Zhai L; Li X; Zeng X
Mol Cells; 2005 Oct; 20(2):183-8. PubMed ID: 16267391
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5.
Zhang ZK; Davies KP; Allen J; Zhu L; Pestell RG; Zagzag D; Kalpana GV
Mol Cell Biol; 2002 Aug; 22(16):5975-88. PubMed ID: 12138206
[TBL] [Abstract][Full Text] [Related]
5. A Coil-to-Helix Transition Serves as a Binding Motif for hSNF5 and BAF155 Interaction.
Han J; Kim I; Park JH; Yun JH; Joo K; Kim T; Park GY; Ryu KS; Ko YJ; Mizutani K; Park SY; Seong RH; Lee J; Suh JY; Lee W
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32244797
[TBL] [Abstract][Full Text] [Related]
6. Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice.
Guidi CJ; Sands AT; Zambrowicz BP; Turner TK; Demers DA; Webster W; Smith TW; Imbalzano AN; Jones SN
Mol Cell Biol; 2001 May; 21(10):3598-603. PubMed ID: 11313485
[TBL] [Abstract][Full Text] [Related]
7. Targeting dependency on a paralog pair of CBP/p300 against de-repression of KREMEN2 in SMARCB1-deficient cancers.
Sasaki M; Kato D; Murakami K; Yoshida H; Takase S; Otsubo T; Ogiwara H
Nat Commun; 2024 Jun; 15(1):4770. PubMed ID: 38839769
[TBL] [Abstract][Full Text] [Related]
8. MAX mutant small-cell lung cancers exhibit impaired activities of MGA-dependent noncanonical polycomb repressive complex.
Llabata P; Torres-Diz M; Gomez A; Tomas-Daza L; Romero OA; Grego-Bessa J; Llinas-Arias P; Valencia A; Esteller M; Javierre BM; Zhang X; Sanchez-Cespedes M
Proc Natl Acad Sci U S A; 2021 Sep; 118(37):. PubMed ID: 34493659
[TBL] [Abstract][Full Text] [Related]
9. Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF.
Radko-Juettner S; Yue H; Myers JA; Carter RD; Robertson AN; Mittal P; Zhu Z; Hansen BS; Donovan KA; Hunkeler M; Rosikiewicz W; Wu Z; McReynolds MG; Roy Burman SS; Schmoker AM; Mageed N; Brown SA; Mobley RJ; Partridge JF; Stewart EA; Pruett-Miller SM; Nabet B; Peng J; Gray NS; Fischer ES; Roberts CWM
Nature; 2024 Apr; 628(8007):442-449. PubMed ID: 38538798
[TBL] [Abstract][Full Text] [Related]
10. A selective high affinity MYC-binding compound inhibits MYC:MAX interaction and MYC-dependent tumor cell proliferation.
Castell A; Yan Q; Fawkner K; Hydbring P; Zhang F; Verschut V; Franco M; Zakaria SM; Bazzar W; Goodwin J; Zinzalla G; Larsson LG
Sci Rep; 2018 Jul; 8(1):10064. PubMed ID: 29968736
[TBL] [Abstract][Full Text] [Related]
11. Elusive and Aggressive: Unraveling
Liu XL; Agostini-Vulaj D
Int J Surg Pathol; 2024 Feb; ():10668969241232699. PubMed ID: 38378024
[TBL] [Abstract][Full Text] [Related]
12. INI1/SMARCB1 Rpt1 domain mimics TAR RNA in binding to integrase to facilitate HIV-1 replication.
Dixit U; Bhutoria S; Wu X; Qiu L; Spira M; Mathew S; Harris R; Adams LJ; Cahill S; Pathak R; Rajesh Kumar P; Nguyen M; Acharya SA; Brenowitz M; Almo SC; Zou X; Steven AC; Cowburn D; Girvin M; Kalpana GV
Nat Commun; 2021 May; 12(1):2743. PubMed ID: 33980829
[TBL] [Abstract][Full Text] [Related]
13. Structure and DNA binding analysis of AT-rich interaction domain present in human BAF-B specific subunit BAF250b.
Giri M; Gupta P; Maulik A; Gracias M; Singh M
Protein Sci; 2022 May; 31(5):e4294. PubMed ID: 35481652
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional-translational conflict is a barrier to cellular transformation and cancer progression.
Jana S; Brahma S; Arora S; Wladyka CL; Hoang P; Blinka S; Hough R; Horn JL; Liu Y; Wang LJ; Depeille P; Smith E; Montgomery RB; Lee JK; Haffner MC; Vakar-Lopez F; Grivas P; Wright JL; Lam HM; Black PC; Roose JP; Ryazanov AG; Subramaniam AR; Henikoff S; Hsieh AC
Cancer Cell; 2023 May; 41(5):853-870.e13. PubMed ID: 37084735
[TBL] [Abstract][Full Text] [Related]
15. The Chromatin Remodeling Component Arid1a Is a Suppressor of Spontaneous Mammary Tumors in Mice.
Kartha N; Shen L; Maskin C; Wallace M; Schimenti JC
Genetics; 2016 Aug; 203(4):1601-11. PubMed ID: 27280691
[TBL] [Abstract][Full Text] [Related]
16. Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells.
Abraham SA; Hopcroft LE; Carrick E; Drotar ME; Dunn K; Williamson AJ; Korfi K; Baquero P; Park LE; Scott MT; Pellicano F; Pierce A; Copland M; Nourse C; Grimmond SM; Vetrie D; Whetton AD; Holyoake TL
Nature; 2016 Jun; 534(7607):341-6. PubMed ID: 27281222
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma.
Abou-Taleb H; Yamaguchi K; Matsumura N; Murakami R; Nakai H; Higasa K; Amano Y; Abiko K; Yoshioka Y; Hamanishi J; Koshiyama M; Baba T; Yamada R; Matsuda F; Konishi I; Mandai M
Oncotarget; 2016 Aug; 7(34):54758-54770. PubMed ID: 27340867
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic synthetic lethality in ovarian clear cell carcinoma: EZH2 and ARID1A mutations.
Bitler BG; Aird KM; Zhang R
Mol Cell Oncol; 2016 Jan; 3(1):e1032476. PubMed ID: 27308548
[TBL] [Abstract][Full Text] [Related]
19. Chromatin remodeling gene AT-rich interactive domain-containing protein 1A suppresses gastric cancer cell proliferation by targeting PIK3CA and PDK1.
Zhang Q; Yan HB; Wang J; Cui SJ; Wang XQ; Jiang YH; Feng L; Yang PY; Liu F
Oncotarget; 2016 Jul; 7(29):46127-46141. PubMed ID: 27323812
[TBL] [Abstract][Full Text] [Related]
20. c-MYC partners with BPTF in human cancer.
Richart L; Real FX; Sanchez-Arevalo Lobo VJ
Mol Cell Oncol; 2016 May; 3(3):e1152346. PubMed ID: 27314097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
